Eldecalcitol (ED-71), an oral vitamin D3 analog, is renowned for its potent inhibition of bone resorption and significant increase in bone mineral density, making it a valuable asset in osteoporosis treatment. Additionally, it exhibits anti-tumor properties by inhibiting cell proliferation, migration, and inducing apoptosis through the suppression of GPx-1, positioning it as a potential agent in cancer research and therapy.
Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.